New England Biolabs (United States)
New England Biolabs is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
72%
Total
Publications
1.8K
Total Open
Publications
1.3K
Total
Citations
108K
Open Access
Percentage
72%
Total
Publications
1.8K
Total Open
Publications
1.3K
Total
Citations
108K
Breakdown
Publisher Open
16%
Both
43%
Other Platform Open
11%
Closed
30%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 64%
631
Hybrid 21%
210
No Guarantees 15%
153
Other Platform Open
Domain 75%
705
Other Internet 25%
234
Institution 23%
217
Public 7%
69
Preprint 0%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 705 |
DOI | Other Internet | 210 |
Figshare | Public | 70 |
Europe PMC | Domain | 68 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 57 |
DASH - Digital Access to Scholarship at Harvard | Institution | 43 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 27 |
Unknown Repository | Other Internet | 26 |
Elsevier - Scopus | Institution | 12 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 8 |